TCL Archive In Brief: Hopkins Gets $10 Million for Directorships, to Dedicate New Clinical Cancer Building October 22, 1999
TCL Archive Community Cancer Control Program Survives Schmidt Criticism; NCAB Votes To Continue October 17, 1975
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Adjuvant Radiation Treatment Shows Improved Survival In Elderly, Early-Stage Patients November 30, 2012
